Flumatinib
Flumatinib (HHGV678) is an orally administered small molecule tyrosine kinase inhibitor with potential antineoplastic properties. It is used in research for targeting BCR-ABL in chronic myeloid leukemia, demonstrating activity in both in vitro cellular assays and in vivo animal models.
Product Specifications
CAS Number
895519-90-1
Product Name Alternative
C-Kit, cKit, CD117, Bcr-Abl, BcrAbl, c-Abl, Inhibitor, inhibit, PDGFR, PDGFRβ, Platelet-derived growth factor receptor, HHGV 678, HHGV678, HHGV-678, Flumatinib, SCFR
Field of Research
Cardiovascular Research, Signal Transduction
Purity
99.39% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.55 mM) ; DMSO:50 mg/mL (88.87 mM)
Smiles
CN1CCN (Cc2ccc (cc2C (F) (F) F) C (=O) Nc2cnc (C) c (Nc3nccc (n3) -c3cccnc3) c2) CC1
Molecular Formula
C29H29F3N8O
Molecular Weight
562.59
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
